FDA Broadens the Spectrum for Evaluating Treatments for Opioid Use Disorder

FDA Broadens the Spectrum for Evaluating Treatments for Opioid Use Disorder  AJMC.com Managed Markets Network FDA knew about dangerous opioid misuse, but failed to intervene, documents show  Becker's Hospital Review FDA gives drugmakers new ways to prove opioid disorder treatments work  ModernHealthcare.com Medication development in opioid addiction: Meaningful clinical end points | Science Translational Medicine  Science Translational Medicine FDA takes new steps to encourage the development of novel medicines for the treatment of opioid use disorder  PR Newswire (press release)Full coverage

(CLICK HERE TO READ AND SEE MORE)